La sténose valvulaire aortique (SVA) est une pathologie associée au vieillissement et aux facteurs de risque cardiovasculaire. Afin d’étudier la SVA et d’explorer de nouvelles thérapies, plusieurs modèles animaux ont été récemment développés, mais la plupart de ces modèles ciblent les mécanismes de développement de la SVA reliés à l’hypercholestérolémie. Le syndrome de Werner (WS) est une maladie caractérisée par un vieillissement prématuré. Récemment, il a été découvert que des souris mutantes ayant une délétion du domaine hélicase du gène Werner, responsable du WS, démontraient un profile hémodynamique typique de la SVA. De ce fait, nous avons émis l’hypothèse que ces souris pourraient développer une SVA plus rapidement que des souris de type sauvage. Nous avons donc étudié les effets cette mutation chez des souris WrnΔhel/Δhel, en comparant le taux de progression d’une SVA entre des souris WrnΔhel/Δhel (WrnΔhel) et des souris de type sauvage comme groupe contrôle. À la suite d’une diète riche en sucre et en gras sur une période de 24 semaines, les souris WrnΔhel ont démontré une diminution plus prononcée de leur aire de valve aortique (mesures échocardiographiques) que les souris contrôles, supportée par les analyses histologiques concernant la fibrose des valves aortiques. Les souris n’ont toutefois développé aucun signe évident d’athérosclérose comme l’infiltration de lipides ou l’inflammation, bien que certaines caractéristiques liées à la dysfonction endothéliale semblent être augmentées chez les souris WrnΔhel. D’autres mesures échocardiographiques indiquant une SVA, comme une hypertrophie du ventricule gauche dans le groupe WrnΔhel, ont été obtenues. Nous avons aussi observé des indices de vieillissement plus marqués quant aux analyses sanguines et de la moelle osseuse des souris WrnΔhel en comparaison avec les souris contrôles. Par conséquent, ce modèle expérimental de vieillissement pourrait être utilisé pour les études futures sur la SVA sans les principaux effets athérogéniques des autres modèles expérimentaux. / Aortic valve stenosis (AVS) is associated with aging and classical cardiovascular risk factors. Different animal models were recently developed to study AVS and explore new therapies, however, most of these models rely almost exclusively on hypercholesterolemia-related mechanisms for AVS development. Werner syndrome (WS) is a disorder characterized by premature aging. It was recently demonstrated that mutant mice with a deletion of the helicase domain of the Werner gene, the gene responsible for WS, showed hemodynamic profile typical of AVS. We therefore hypothesized that mice with the WrnΔhel deletion could develop AVS earlier than wild-type (WT) mice. We studied the effect of the WrnΔhel mutation by comparing the rate of progression of AVS in homozygous mutant versus WT mice. By twenty-four weeks on a high-fat/high-carbohydrate diet, WrnΔhel/Δhel (WrnΔhel) mice showed a stronger decrease of the aortic valve area measured by serial echocardiography than WT mice, supported by histological analyses of valve fibrosis but without developing major signs of atherosclerosis such as lipid infiltration or increased inflammation. Some features linked to endothelial dysfunction also appeared to be increased in WrnΔhel mice. Other echocardiographic measurements were typical of AVS, such as left ventricle hypertrophy in the WrnΔhel group. We also observed stronger aging properties from WrnΔhel mice bone marrow and blood analyses compared to the WT group. Consequently, this experimental aging model could be used for AVS research without the major confounding atherogenic effects of other experimental models.

La rupture de la plaque d'athérome carotidienne est la première cause des infarctus cérébraux. Pour prévenir ces accidents, l'endartérectomie carotidienne est le traitement le plus utilisé. La vulnérabilité de la plaque est en relation avec les efforts que le sang applique sur la plaque. Ces actions sont différentes suivant les propriétés constitutives, mécaniques et géométriques de la plaque. Plusieurs auteurs ont développé des modèles numériques de la plaque d'athérome carotidienne à partir desquels une analyse mécanique a permis de caractériser les déformations et les contraintes en lien avec la rupture de la plaque. Néanmoins, les caractéristiques d'une plaque vulnérable sont encore mal connues. Dans ce manuscrit, un modèle numérique de plaque d'athérome carotidienne est développé en interaction fluide-structure dans le but mieux comprendre comment les actions mécaniques du sang sur la plaque sont affectées par les propriétés mécaniques et géométriques de la plaque. Plusieurs résultats sont en concordance avec la littérature : la vulnérabilité de la plaque est associée à la sévérité de sténose et à l'épaisseur de la chape fibreuse. De plus une analyse de l'écoulement du sang, de la déformation de la plaque et des contraintes dans la plaque révèle que les effets de l'écoulement du sang sont amplifiés si la plaque est courte, si la pente en amont de sténose est raide ou si la morphologie de la plaque est irrégulière et asymétrique. Ces résultats offrent de nouvelles perspectives dans la compréhension de la vulnérabilité de la plaque. / The rupture of carotid atheromatous plaques is the major cause of cerebrovascular thromboembolic events such as strokes and ischemic attacks. To prevent this issue, carotid endarterectomy is the preferred treatment. The vulnerability of the plaque is related the mechanical action of the blood onto the plaque. This action is different according to the plaque morphology, the plaque constitution and the mechanical properties of the constituents. Several authors developed computational models to perform mechanical analyses for carotid atherosclerotic plaques and to identify critical mechanical descriptors as stresses or strains related to plaque rupture. But the question of which plaque characteristics affect the plaque rupture is not closely elucidated. In this manuscript a fluid structure interaction model is developed, questioning how the mechanical action of the blood onto an atheromatous plaque is affected by the mechanical and geometrical properties of the plaque. Many results are in agreement with the literature: the vulnerability of atheromatous plaques is related to the degree of severity of the endoluminal stenosis and the thickness of the fibrous cap. Moreover the resulting flow patterns, wall shear stresses, plaque deformations and stresses in the fibrous cap reveal that the effects of the blood flow are amplified if the plaque is short, if the slope upstream stenosis is steep or if the plaque morphology is irregular and asymmetric. These results offer new perspectives for understanding the vulnerability of plaques.

En pathologie lombaire dégénérative, [des] procédures chirurgicales peuvent être employées pour répondre aux situations clinicoradiologiques rencontrées. Ces procédures sont efficaces mais invasives et grevées d'un taux de complications non négligeables. Les dispositifs interépineux (DIE) [diminuent] ainsi la morbidité. Cependant leur efficacité est controversée. Les effets des DIE peuvent être appréciés sur la modification cinématique de l'étage implanté et sur la modification de la taille des foramens. A travers une série d'études biomécaniques cadavériques, les auteurs tentent de vérifier s'il existe bien ces effets attendus avec 4 dispositifs différents. Concernant L4, DIAM® et In-Space® n'avaient aucun effet contrairement à Wallis qui avait un effet significatif en flexion et en extension. Concernant L5, aucun implant n'avait d'effet en flexion, alors que tous avaient un effet amortissant en extension. Il n'y avait pas d'implant supérieur aux autres. Concernant les variations de mobilité, Wallis® est l'implant qui diminue le plus les amplitudes globales de L4 et L5, de l'ordre de 50% et 42.7%, respectivement. […] Une étude cadavérique de la surface latérale du foramen intervertébrale par méthode photographique et binarisation des images a permis de montrer qu'avec le YODA, la longueur moyenne du foramen était de 15.7±2.8mm et la largeur moyenne de 9.4±1.2mm. Après implantation des DIE, ces dimensions variaient respectivement à 16.8±2.5mm et 10.1±1.3mm. La surface foraminale moyenne était de 150.4±35.8 mm2 à vide et de 165.1±28.3mm2, après implantation. Le gain moyen était de 14.7mm2 (5.3-26.9). Cependant, cet implant n'avait aucun effet sur la cinématique de l'étage implanté, même en extension, justifiant de discuter une modification de sa structure. La mesure stéréoscopique 3D des variations de surface foraminale L4-L5 et des foramens adjacents a permis de montrer que tous les implants ouvrent le foramen L4-L5 en extension. Deux catégories d'implants : 1 qui ouvrent le foramen en position neutre, en flexion et en extension ; 2 qui ferment le foramen en flexion mais l'ouvrent en extension. La mise en place des implants en L4-L5 n'avait aucune conséquence sur la taille du foramen à l'étage L3-L4. En revanche, XSTOP et DIAM entraînaient une fermeture minime du foramen L5-S1 vers l'extension. La mesure de surface nous a semblé insuffisante pour évaluer la globalité de la sténose. Nous avons développé une nouvelle mesure de la taille du foramen en appréciant son volume au scanner. Avec cette technique de mesure, le volume moyen de 60 foramens et de 20 foramens L4-L5 étaient respectivement de 1.17±0.23 et de 1.25±0.27 mm3 pour l'observateur 1 et de 1.21±0.21 et 1.29±0.23 mm3 pour l'observateur 2. Les CIC intra observateurs pour l'observateur 1 pour la mesure de l'ensemble des foramens et pour L4-L5 étaient de 0.98 et 0.99. Pour l'observateur 2, les CIC étaient de 0.90 et 0.92, respectivement. Les CIC inter observateurs pour l'observateur 1 pour la mesure de l'ensemble des foramens et pour L4-L5 étaient de 0.78 et 0.83. Pour l'observateur 2, les CIC étaient de 77 et 0.8. La moyenne des différences de mesures entre les observateurs étaient de moins de 0.2 mm3 (0.05 and 0.15). […] L'excellente reproductibilité de cette mesure simple complète les outils de mesure de la taille du foramen. La validation de cette mesure du volume a permis de vérifier s'il y avait ou pas, une variation du volume foraminal après implantation comparative des quatre dispositifs inter épineux. Les volumes des foramens L4-L5 étaient significativement augmentés après implantation de INSPACE®, XSTOP® et WALLIS®. Le volume foraminal moyen de l'étage sus jacent n'était pas modifié et seul le WALLIS® diminuait le volume en L5-S1. XSTOP® : l’implant qui ouvrait le plus les foramens. Les dispositifs interépineux ont bien des effets biomécaniques sur l'étage implanté, aussi bien en cinématique que sur les variations de la taille du foramen intervertébral. / In lumbar degenerative disease, many surgical procedures can be used to respond to different radiological clinical situations. These invasive procedures are effective, but with a significant complication rate. Interspinous devices (DIE) are positioned with more limited approaches, thereby reducing morbidity. However, their effectiveness is controversial. The effects of EIS can be evaluated on the kinematic changes of the implanted level and changing in the foramina size. Through a series of cadaveric biomechanical studies, the authors try to check if these are good effects expected with 4 devices. Concerning L4, DIAM® and In-Space® had no effect on either flexion or extension, contrary to Wallis®, which had a significant effect on flexion and extension. Concerning L5, no implant had an effect in flexion, while all presented a significant amortisation effect on extension.No significant difference was revealed between implants on flexion, in extension or on a global cycle. Concerning the mobility variations, Wallis® is the implant which decreases the global average movement of L4 and L5 the most, by 50% and 42.7%, respectively.The analysis of variations in the size of foramina is still confidential. Few authors are concerned. A cadaver study of the lateral surface of the intervertebral foramen by photographic method and binarization images has shown that with YODA, the average length of foramen was 15.7 ± 2.8mm and the average width of 9.4 ± 1.2mm. After implantation of DIE, these dimensions ranged respectively 16.8 ± 2.5mm and 10.1 ± 1.3mm. The mean foraminal area was 150.4 ± 35.8 mm2 vacuum and 165.1 ± 28.3mm2 after implantation. The average gain was 14.7mm2 (5.3-26.9). However, this implant has no effect on the kinematics of the implanted level even in extension justifying discuss a modification of the implant. Stereoscopic 3D measuring foraminal area variations on L4-L5 level and adjacent foramina has shown that all implants open the L4-L5 foramen in extension. There seems to be two types of implants: those who open the foramen in neutral, flexion and extension, and those who close the foramen bending but open to extension. There were no effects on the size of the foramen L3 -L4. However, Xstop and DIAM resulted minimal closure L5-S1 foramen to the extension. Surface measurement seemed insufficient to assess the totality of the stenosis. We developed a new measure of the foramen size enjoying its volume scanner. With this measurement technic, the mean volume of 60 foramen and 20 L4-L5 foramen were respectively 1.17 ± 0.23 and 1.25 mm 3 ± 0.27 for the observer 1 and 1.21 ± 0.21 and 1.29 ± 0.23 mm 3 for the observer 2. The intra observer CIC 1 for the observer for all measuring foramina and L4 - L5 were 0.98 and 0.99, respectively. For observer 2, ICC were 0.90 and 0.92, respectively. The inter-observer CIC for the observer 1 for measuring all foramina and L4 - L5 were 0.78 and 0.83, respectively. For observer 2, the CIC were 77 and 0.8, respectively.The average differences in measurements between observers were less than 0.2 mm3 (0.05 et 0.15). This is the first study to measure the volume of the foraminal scanner. The excellent reproducibility of this simple measure complements the tools to measure the size of the foramen. The validation of this volume measurement was used to check whether or not there was a change in the foraminal volume after comparative implementation of four interspinous devices. L4-L5 foramina volumes were significantly increased after implantation of InSpace ®, Xstop ® and WALLIS ®. The average volume of the underlying foraminal volume was not changed and only WALLIS ® decreased the volume L5 -S1. Interspinous devices have many biomechanical effects on the implanted level, as well as kinematic changes in the size (area and volume) of the intervertebral foramen. They have no impact on adjacent

(v AJ) Introduction to the topic and importance of the topic: Aortic valve disease is the third most frequent cardiovascular disease and also the most frequently operated valvular disease in adulthood. The natural process of the disease is unfavorable, almost half of the patients suffer from symptoms of heart failure (Branny et al. 2012). This is the reason why I focused my thesis on the assessment of the quality of life of patients diagnosed of aortic stenosis. Aim of the thesis and research questions: The aim of my thesis is to evaluate the quality of life patients with diagnosed aortic valve disease, within one month before the planned surgery and in the postoperative period when patients will be checked at a cardiac surgery clinic. The partial objective at the same time was to compare the quality of life and health status of patients with aortic valve disease who have completed a spa therapy with those who have rejected it. Methodology (method, research sample): The research work will be carried out as a quantitative research in a group of 29 respondents. The HRQoL construct it means questionnaire SF-36 were used to obtain the data. The questionnaire was anonymous. For the completed questionnaires, a closed box was set up, which I didn't open until the poll was complete. The survey was...

Introdução: As doenças cerebrovasculares constituem-se um sério problema de saúde, e dados sobre sua prevalência mundial são alarmantes. A doença aterosclerótica dos vasos cervicais é um importante fator etiológico de isquêmica cerebral, por mecanismos que envolvem fenômenos embólicos e hipofluxo cerebral. Enquanto o manejo dos pacientes com estenose carotídea sintomática geralmente requer procedimentos cruentos como a endarterectomia e a angioplatia com stent carotídeo, não estão bem definidos o espectro clínico e o manejo adequado dos pacientes com estenoses carotídeas ditas assintomáticas (sem evidência de evento cerebrovascular ipsilateral). Neste contexto, é possível que a presença de déficits cognitivos e as alterações estruturais e funcionais na ressonância magnética cerebral possam ser úteis para a estratificação e o manejo destes pacientes. Objetivos: constitui objetivo principal do presente estudo investigar associações entre biomarcadores de ressonância magnética e desempenho cognitivo, em sujeitos com estenose carotídea assintomática unilateral. Métodos: foram incluídos na pesquisa 13 voluntários, com diagnóstico de doença aterosclerótica assintomática unilateral com comprometimento >= 70% da luz do vaso, recrutados nos ambulatórios de neurologia e cirurgia vascular, do Hospital das Clínicas, da Faculdade de Medicina de Ribeirão Preto - FMRP/ USP. Participaram do grupo controle 13 voluntários, sem antecedentes de doenças cerebrovasculares. A avaliação neuropsicológica consistiu na aplicação do Subteste Dígitos (WAIS); Trail Making Test; Stroop Test; Teste das Figuras Complexas de Rey; provas de fluência verbal fonêmica e categoria semântica; e o Mini Exame do Estado Mental, edições 1 e 2. Para a composição da avaliação de neuroimagem por ressonância magnética, foram inclusas: (1) imagens FLAIR (fluid attenuated inversion recovery) para avaliação de carga de lesão de substância branca; (2) imagens de ASL (arterial spin labeling), ponderadas em perfusão sanguínea, para quantificação do fluxo sanguíneo cerebral; e (3) imagens baseadas no contraste BOLD (blood oxygenation level dependent), em repouso, para avaliação da conectividade funcional. Análises estatísticas foram realizadas pelo Stata 15.1, em que as variáveis foram testadas para normalidade usando o teste de normalidade de Shapiro-Wilk. O teste t de amostras independentes e o teste U de Mann-Whitney foram utilizados para analisar as diferenças entre os grupos. As diferenças hemisféricas na carga de WMH foram testadas pelo teste t pareado, ou Wilcoxon. Testes Chi-squared ou Teste Exato de Fisher foram utilizados na análise de variáveis categóricas. Os coeficientes decorrelação de Pearson ou Spearman foram utilizados para explorar correlações entre escores cognitivos, volume de substância branca, carga de WMH, CBF e conectividade funcional. Resultados: O volume de substância branca (SB) em pacientes com estenose carotídea assintomática mostrou-se marcadamente reduzido, enquanto hiperintensidade de sinal em SB esteve significativamente aumentada em relação a indivíduos controles (p < 0,01). O hemisfério ipsilateral à estenose assintomática grave apresentou carga mais expressiva de lesão em SB (p = 0,01). Neste contexto, a presença de estenose assintomática esteve independentemente associada à hiperintensidade de SB. Análises de CBF não revelaram diferenças entre os grupos clínicos e controle, embora o CBF tenha sido associado ao desempenho das funções cognitivas em todos os domínios avaliados por este estudo. Não foram identificadas diferenças de fluxo sanguíneo global em territórios das artérias cerebrais anterior, média e posterior, entre sujeitos com estenose de artéria carótida assintomática e controles. Pacientes apresentaram prejuízos de conectividade em redes cerebrais de repouso (RSBNs), especialmente frontotemporal, saliência e rede atencional dorsal, em relação aos controles (p-FDR < 0,01). A performance cognitiva de pacientes com estenose carotídea foi inferior ao grupo controle, para todas as medidas, com diferenças significativas em domínios mnemônicos, atencionais e funções executivas (p<0.05), estes relacionados com RSBNs. Conclusões: Nós identificamos anormalidades pré-clínicas no volume de SB, CBF, conectividade funcional e no desempenho cognitivo de pacientes com estenose carotídea assintomática. Biomarcadores de neuroimagem na RM, combinados à avaliação cognitiva têm um grande potencial para identificação de pacientes com estenose carotídea assintomática sob risco elevado de AVC e declínio cognitivo. / Background: Cerebrovascular diseases are an important health problem worldwide with high prevalence, mortality and morbidity. Among its etiological subtypes, atherosclerotic disease involving the carotid artery is strongly associated with ischemic stroke due to arterial embolism and hemodynamic compromise. The management of symptomatic carotid stenosis generally requires carotid endarterectomy or stenting. Nevertheless, the management of asymptomatic carotid stenosis and patient selection for these procedures is still largely debated. It is possible that the presence of cognitive impairment, alterations on functional and structural magnetic resonance imaging (MRI) biomarkers of cerebrovascular disease could help the stratification and management of these patients. Objetives: to investigate the association between MRI biomarker of cerebrovascular disease and cognitive function in patient with unilateral asymptomatic carotid stenosis. Methods: we evaluated 13 patients with unilateral carotid stenosis >= 70% recruited from a tertiary academic outpatient clinic in Brazil and 13 control subjects without carotid stenosis or history of cerebrovascular diseases paired by age and sex. The neuropsycological evaluation included the WAIS, Trail Making Test; Stroop Test; Rey complex figures test; verbal fluency and categorical semantic fluency; and the minimental state 1 and 2. The MRI evaluation included: (1) FLAIR evaluation of white matter (WM) burden; (2) ASL evaluation of cerebral blood flow (CBF); (3) resting-state BOLD for evaluation of functional connectivity. Statistical analyses were performed with the Stata 15.1 package. Normality of the distribution of the variables was assessed with the Shapiro-Wilk test. We also used the student t test, Mann-whytney test, Chi-squared test and Fisher exact test as appropriate for univariate analyses. Pearson and Spearman correlation coefficients were used to explore the correlations among cognitive performance scores, WM volume, burden of WM hyperintensities, CBF and brain functional connectivity. Results: the global WM volume was markedly reduced and the global WM hyperintensity was significantly increased within the ipsilateral hemisphere in patients with unilateral carotid stenosis, when compared to controls (p < 0,01). CBF evaluated by ASL was associated with cognitive function but it was not significantly different between patients and controls within the arterial territories of the major intracranial arteries. Patients with carotid stenosis showed marked compromise of the brain connectivity within the frontotemporal, attentional and salience networks when compared to controls (p-FDR < 0,01). The cognitive performance was inferior for patients with unilateral carotid stenosis compared to controls in several cognitivedomains including executive function, attention and mnemonic domains. Conclusions: patients with asymptomatic carotid stenosis have high frequency of pre-clinical abnormalities on structural and functional MRI biomarkers and cognitive impairment. Evaluation of cognitive function, structural and functional MRI biomarkers of cerebrovascular disease may have a role to improve patient stratification and selection for interventions among patients with unilateral carotid stenosis.

Introdução: A doença aterosclerótica intracraniana é uma das principais causas de acidente vascular cerebral isquêmico (AVCI) no mundo, porém sua prevalência parece estar subestimada na população brasileira pela carência de estudos na área. O objetivo principal deste estudo foi descrever a frequência e gravidade da estenose intracraniana nos pacientes com AVCI ou ataque isquêmico transitório (AIT), utilizando a ultrassonografia transcraniana colorida (UTC). O objetivo secundário foi correlacionar os achados deste exame com a angiotomografia de crânio (AngioTC). Métodos: estudo observacional e prospectivo, onde foram avaliados pacientes consecutivos com o diagnóstico de AVCI ou AIT admitidos no período de fevereiro de 2014 a dezembro de 2014. A avaliação inicial consistiu na coleta de dados demográficos, epidemiológicos e clínicos e em seguida os pacientes foram submetidos ao exame de UTC através das janelas transtemporais e suboccipital, com o intuito de avaliar a presença de estenose intracraniana. Estenose intracraniana foi graduada em moderada (50- 70%), grave (70-99%) e suboclusão/oclusão (>= 99%). Foram considerados sintomáticos os casos em que houve uma associação entre os novos sinais e sintomas e uma nova área de infarto ao exame de neuroimagem no território da artéria envolvida ou quando o quadro neurológico correspondeu ao território da artéria envolvida. Os pacientes que possuíam UTC e AngioTC em sua avaliação foram comparados de forma cega quanto ao grau de estenose intracraniana seguindo a mesma classificação. Resultados: Foram avaliados 271 pacientes com o diagnóstico de AVCI ou AIT agudos (149 homens, com média de idade de 65,8 ± 12,5), 263 (97%) foram submetidos a exame de circulação intracraniana, sendo a ultrassonografia transcraniana colorida realizada em 168 casos (61,9%). Apenas 25 indivíduos (14,9%) foram excluídos devido a janela transtemporal insuficiente. Dentre os 143 pacientes que puderam ser avaliados adequadamente pela ultrassonografia transcraniana, a prevalência de estenose arterial intracraniana foi de 38,5% (55 casos); sendo sintomática em 25,2% dos casos. A média de idade dos pacientes era de 64 ± 11 anos, 26,9 % eram brancos e 29,4% hipertensos. Os pacientes com estenose intracraniana apresentaram maior pontuação na escala do NIH: 10 (IQ 4 - 19) vs 6 (IQ 3 - 13), maiores níveis de pressão arterial sistólica na admissão: 160 (IQ 145-170) vs 140 (IQ 130 - 155) e menores taxas de HDL: 32 (IQ 27 - 39) vs 36 (IQ 30 - 45). Após análise multivariada, o fator de risco independentemente associado à estenose intracraniana foi a hipertesão arterial sistêmica na admissão (p=0,006). Nos 100 pacientes com ambos os exames, a sensibilidade, especificidade, valor preditivo positivo e valor preditivo negativo da UTC comparada a AngioTC para detecção de estenoses intracranianas moderadas-graves foi de 60%, 73%, 73% e 60%, respectivamente. Conclusões: Encontramos alta frequência de estenose arterial intracraniana entre os pacientes com AVCI agudo e AIT na nossa população, especialmente entre indivíduos portadores de hipertensão arterial sistêmica. A UTC é uma ferramenta não-invasiva que pode ser utilizada para investigação da doença moderada-grave com acurácia moderada quando comparada a AngioTC / Background: Intracranial atherosclerotic disease is a major cause of ischemic stroke in the world, but its prevalence seems to be underestimated in our population by the lack of studies in the area. The aim of this study was to describe the frequency and severity of intracranial stenosis in patients with acute ischemic stroke (AIS) or transient ischemic attack (TIA), using the transcranial color-coded sonography (TCCS). The secondary objective was to correlate the TCCS test results with the findings on CT angiography on the same patients. Methods: Prospective observational study that evaluated consecutive patients admitted with a diagnosis of ischemic stroke or TIA during the period February 2014 to December 2014. The initial evaluation consisted of collection of demographic, epidemiological and clinical data and then the patients underwent the examination TCCS through transtemporal and suboccipital windows, in order to assess the presence of intracranial stenosis. Intracranial stenosis was graded moderate (50-70%), severe (70-99%) and subocclusion/occlusion (>= 99%). The cases were considered symptomatic when there was an association between new symptoms and signs and a new infarct area on neuroimaging in the territory of the stenotic artery or when the neurological status corresponded to the territory of that artery. Patients who had TCCS and intracranial angiography in their assessment were blindly compared for the degree of intracranial stenosis following the same classification. Results: We evaluated 271 patients with diagnosis of acute ischemic stroke and TIA (149 men, mean age 65.8 ± 12.5), 263 (97%) underwent examination of intracranial circulation, with the TCCS held in 168 cases (61.9%). Only 25 individuals (14.9%) were excluded due to insufficient transtemporal window. Among the 143 patients who could be evaluated properly by transcranial ultrasound, the prevalence of intracranial arterial stenosis was 38.5% (55 cases); with 25,2% symptomatic cases. The average age of patients was 64 ± 11 years, 26.9% were white and 29.4% hypertensive. Patients with intracranial stenosis had higher scores on the NIHSS: 10 (IR 4-19) vs 6 (IR 3- 13), higher levels of systolic blood pressure at entry: 160 (IR 145-170) vs 140 (IR 130 - 155) and lower HDL rates: 32 (IR 27-39) vs 36 (IR 30-45). After multivariate analysis, the risk factor independently associated with intracranial stenosis was systemic arterial hypertension at admission (p = 0.006). In the 83 patients with both tests, the sensitivity, specificity, positive predictive value and negative predictive value of TCCS compared to CT angiography for detection of intracranial stenosis moderate-severe was 60%, 73%, 73% e 60%, respectively, Conclusions: We found a high frequency of intracranial artery stenosis in patients with acute ischemic stroke and TIA in our population, especially among individuals with hypertension. TCCS is a non-invasive tool that can be used to study moderate-severe disease with moderate accuracy compared to CT angiography

INTRODUÇÃO: A estenose carotídea de origem aterosclerótica é um importante marcador de aterosclerose sistêmica avançada. A oclusão (obstrução completa da artéria) é rara e corresponde ao evento morfológico final da progressão da placa de ateroma na bifurcação carotídea. Muitos pacientes são sintomáticos no momento do diagnóstico e apresentam novos sintomas neurológicos na evolução apesar de tratamento clínico adequado. A literatura médica é escassa em determinar os principais fatores que podem levar a oclusão carotídea. A participação e intensidade das comorbidades e/ou fatores de risco, associados a dados demográficos peculiares foram pouco explorados. OBJETIVOS: Caracterizar o paciente com oclusão carotídea (OC) quanto a aspectos demográficos, doenças associadas e fatores de risco; detectar novos eventos neurológicos, cardiovasculares e óbitos no seguimento clínico destes pacientes. MÉTODO: Informações demográficas, clinicas e evolutivas de pacientes com oclusão carotídea e estenose carotídea não significativa foram recuperadas de um banco de dados compÍetado prospectivamente e complementadas com prontuário hospitalar e novos dados obtidos via convocação e/ou entrevista telefônica. RESULTADOS: No período de janeiro de 2005 a janeiro de 2013 foram analisados 213 pacientes portadores de OC e 172 portadores de estenose hemodinamicamente não significativa (ENS), ou abaixo de 50%. Foram analisados 4 dados demográficos e 9 fatores de risco, bem como sintomas neurológicos na apresentação e na evolução. No grupo OC predominaram indivíduos do sexo masculino, hipertensos, tabagistas, portadores de doença arterial obstrutiva periférica (DAOP), insuficiência renal crônica (IRC) com significância estatística em relação ao grupo ENS (p < 0,05).\\.Entre os pacientes com OC, 76,1% apresentaram sintomas neurológicos inicialmente contra 35,5% do grupo ENS (p = 0,000001). Quanto à evolução, os pacientes com OC apresentaram progressão significativa da estenose carotídea contralateral, quando comparada com a progressão da estenose nas carótidas do grupo ENS. (15,0% e 2,3%, p = 0,00011). O aparecimento de novos sintomas foi determinado pelo estado clínico de apresentação dos pacientes: 10,8% de novos sintomas nos inicialmente sintomáticos e 4,3% nos assintomáticos (p = 0,0218). Constatou-se maior número de óbitos na amostra OC (14,1%) do que na ENS (6,4%) com diferença significativa (p = 0,0150). CONCLUSÕES: OS pacientes portadores de OC apresentam maior prevalência de fatores de risco e comorbidades e maior mortalidade que o grupo ENS. No seguimento, os pacientes que se apresentavam sintomas neurológicos no momento do diagnóstico foram aqueles que mais desenvolveram novos eventos neurológicos. Este estudo representa um esforço em identificar uma amostra da população com estenose carotídea que pode necessitar de diagnóstico precoce e intervenção clínica vigorosa na prevenção de novos eventos e/ou óbitos / INTRODUCTION: Carotid stenosis is an important marker of severe systemic atherosclerosis. Internal Carotid occlusion (ICO) is rare and represents the final event when it comes to atherosclerotic plaque progression at the carotid bifurcation. Many patients are symptomatic when diagnosed with this condition and some of them will present more neurologic symptoms despite proper clinical management. So far only few studies have investigated if more comorbidities andjor risk factors, associated to demographic characteristics can lead to ICO. OBJETIVES: To identify the patient with ICO as regard to his demographic data, associated diseases and risk factors. Primary end-points were new neurologic events, cardiovascular symptoms and deaths during follow-up. METHOD: A prospective database was completed with demographic data and clinical information from patients with ICO and from a control group of patients with a non-significant stenosis (NSS), ar below 50%. Information was collected retrospectively from clínical records and missing data were completed with a medical appointment or teJephone interview. RESULTS: From [anuary 2005 to [anuary 2013, 213 patients with ICO and 172 patients with NSS were studied. Demographic data, risk factors for atherosclerosis and neurological symptoms at diagnosis and during follow-up were verified. Among patients with [CO there were more men and those with history of smoking, and more patients presenting with peripheral arterial disease (PAD) and chronic renal failure (CRF) than those in the NSS group (p < 0,05). At the time of diagnosis 76.1% of patients with ICO were symptomatic, while 35.5% in the NSS group (p=0.000001). Patients in the ICO group presented significant progression of the contralateral stenosis when compared to progression on any side in the control grouP\'\"(15.0% versus 2.3%, p = 0.00011). New symptoms were determined by the patient\'s clinical status. As regard to new neurological symptoms during follow-up, 10.8% of those initially symptomatic (both groups combined), presented new symptoms, opposed to 4.3% of those initially asymptomatic (p=0.0218). Number of deaths was significantly higher among patients in the ICO group (14.1% versus 6.4%, p=0.0150). CONCLUSIONS: Patients presenting with ICO have more risk factors and higher mortality by any cause. Those initially symptomatic will likely present more neurological symptoms during follow up. This study aims to identify those who are more at risk before the occlusion and could benefit of earJy diagnosis and vigorous c1inical intervention before new neurological events andjor death

Introdução: Uma nova alternativa de tratamento foi desenvolvida, o Implante por Cateter de Bioprótese Valvar Aórtica (TAVI, em inglês, Transcatheter Aortic Valve Implantation), indicado para os pacientes portadores de estenose aórtica grave com várias comorbidades, considerados inoperáveis pelo tratamento cirúrgico convencional. O TAVI ainda não foi incorporado ao rol de políticas de saúde do Brasil pelo Sistema Único de Saúde (SUS), tampouco pela Agência Nacional de Saúde Suplementar (ANS), pois há escassez de evidências científicas fundamentadas em análise econômica do procedimento que relatem os resultados e o custo a longo prazo em comparação à cirurgia convencional. Objetivo: Identificar o custo direto médio do implante por cateter de bioprótese valvar aórtica, verificar se há alteração significativa de custo nas diferentes vias de acesso utilizadas e identificar os fatores preditores que possam elevar o custo do procedimento. Método: Trata-se de uma pesquisa com abordagens quantitativa, exploratória, descritiva, transversal, retrospectiva e documental, realizada em um hospital da Secretaria de Estado de Saúde de São Paulo (SES-SP), da Administração Direta, especializado no tratamento de doenças cardiovasculares de alta complexidade. A população do estudo correspondeu aos procedimentos eletivos do TAVI, desde a inauguração da sala híbrida, em março de 2012, até agosto de 2015, totalizando 108 procedimentos, sendo 92 por via transfemoral, 8 por via transapical e 8 por via transaórtica. Resultados: O custo direto médio dos procedimentos TAVI nas três vias totalizou R$ 82.230,94. Por via transfemoral, esse custo médio foi de R$ 82.826,38; por via transaórtica, R$ 79.440,91; e por via transapical, R$ 78.173,41. O total de material e medicamento/solução representou, por via transfemoral, 91,89% do total do custo direto médio do procedimento TAVI; por via transapical, 91,81%; e por via transaórtica, 90,69%, e o custo fixo com a válvula transcateter, no valor de R$ 65 mil, representou 78,47% sobre o custo total do procedimento TAVI, por via transfemoral; 83,14%, por via transapical; e 81,82%, por via transaórtica. O Teste Kruskal-Wallis Teste das Variáveis Contínuas apresentou diferença estatisticamente significativa entre as vias de acesso. No custo total do procedimento TAVI, o Teste de Bonferroni mostrou diferença na associação entre as vias transfemoral e transapical. No entanto, na associação com a via transaórtica, não apresentou diferença estatisticamente significativa. Os fatores preditores que elevaram o custo do procedimento TAVI foram: vias de acesso, duração do procedimento, material de hemodinâmica, medicamento/solução, material de consumo, material de perfusão, total de material e medicamento/solução, recursos humanos, gases medicinais, depreciação e energia. A segunda válvula foi a única variável referente às intercorrências no Centro Cirúrgico que elevou o custo do procedimento. A média de idade dos pacientes com indicação ao TAVI foi de 81,50 ±6,96 anos. Conclusão: O TAVI é um avanço a ser discutido e acompanhado, havendo a necessidade de reforçar novas pesquisas que avaliem os benefícios do tratamento com base nos resultados e custos, a fim de auxiliar na tomada de decisão para incorporação desse tratamento para o público-alvo, melhorando a qualidade de vida dos pacientes e proporcionando a integração destes novamente às atividades diárias. / Introduction: A new treatment alternative has been developed, the Transcatheter Aortic Valve Implantation (TAVI), indicated for patients with severe aortic stenosis with various comorbidities deemed inoperable by conventional surgical treatment. TAVI has not yet been incorporated into the Brazilian health policies by the Public Health System (SUS), or by the National Supplementary Health Agency (ANS), because there is a shortage of scientific evidence based on an economic analysis of the procedure that reports the results and the long-term costs compared to conventional surgery. Objective: To identify the average direct cost of the transcatheter aortic valve implantation, to verify if there is significant change of cost in the different access routes used, and to identify predictive factors that could increase the cost of the procedure. Method: This is a study with quantitative, exploratory, descriptive, transversal, retrospective, and documentary approaches, carried out in a hospital of the State Department of Health of São Paulo (SES-SP), of the Direct Administration, specialized in the treatment of high-complexity cardiovascular diseases. The study population corresponded to TAVI elective procedures, from the inauguration of the hybrid room, in March 2012, up to August 2015, totaling 108 procedures, of which 92 were transfemoral, 8 were transapical, and 8 were transaortic. Results: The average direct cost of the TAVI procedures in the three routes totaled R$ 82,230.94. Transfemorally, this average cost was R$ 82,826.38; through the transaortic route, R$ 79,440.91; and through the transapical route, R$ 78,173.41. The total material and medication / solution represented 91.89% of the total average direct cost of the TAVI procedure through the transfemoral route; 91.81% through the transapical route; and 90.69% through the transaortic route, and the fixed cost with the transcatheter valve, in the amount of R$ 65,000.00, represented 78.47% of the total cost of the TAVI procedure through the transfemoral route; 83.14%, through the transapical route; and 81.82% through the transaortic route. The Kruskal-Wallis Test Continuous Variables Test showed a statistically significant difference among the access routes. In the total cost of the TAVI procedure, the Bonferroni Test showed a difference in the association between the transfemoral and transapical routes. However, in the association with the transaortic route, there was no statistically significant difference. Predictive factors that increased the cost of the TAVI procedure were: access routes, length of procedure, hemodynamic material, drug / solution, consumption material, infusion material, total material and medicine/solution, human resources, medical gas, depreciation and energy. The second valve was the only variable related to the complications in the or that increased the cost of the procedure. The mean age of patients with TAVI was 81.50 ± 6.96 years. Conclusion: TAVI is an advance to be discussed and monitored, and there is a need to encourage new studies that evaluate the benefits of treatment based on the results and costs, in order to assist in the decision making for the incorporation of this treatment into its population, improving the quality of life of patients and providing once again their integration into daily activities.

A degradação da matriz extracelular e de proteínas da parede aórtica associada à inflamação é uma das principais características dos aneurismas da aorta abdominal (AAA). O objetivo deste trabalho foi investigar a participação das metaloproteinases 2 e 9 na formação de AAAs, através de um modelo experimental inédito de indução de AAA em ratos Wistar, desencadeado por duas potenciais causas de secreção e ativação de MMP-2 e 9: alteração do fluxo sanguíneo e lesão vascular externa na aorta. A formação de aneurismas foi observada em 60%-70% dos animais, apresentando diâmetro de 7 a 8 vezes maior que o diâmetro normal da aorta. Histologicamente observou-se remodelamento, intensa resposta inflamatória, destruição maciça de fibras elásticas e aumento da síntese de colágeno na parede aórtica. A expressão de ambas as formas de MMP-2 foram observadas tanto nos AAAs como nos grupos controles, neste com menor atividade, entretanto a expressão da pró e da MMP-9 ativa foram encontradas apenas nos AAAs. Conclusão: Nossos resultados sugerem que tanto as MMP-2 quanto as MMP-9 apresentam importante papel no desenvolvimento de AAA e este novo modelo de indução de AAA, pode ajudar a elucidar os mecanismos que desencadeiam a secreção e ativação das MMP-2 e MMP-9 na formação de aneurismas. / Degradation of extracellular matrix and proteins associated with inflammation of the aortic wall is the main characteristics of the abdominal aortic aneurysms (AAA). The aim of this study was investigate the participation of Metalloproteinase 2 and 9 in AAA formation in Wistar rats. A novel experimental model of AAA was developed, providing two potential causes of MMPs secretion and activation, turbulent flow (caused by surgically induced extrinsic stenosis) and outside vascular injury is detailed described. The days analyzed were the 3rd and the 7th post surgery. Aneurysms were observed to occur in 60-70% of the Group AAA, exhibiting a major transversal diameter to 7 from 8 times larger than controls and sham groups. Histologically, the aneurysms wall showed extensive structural remodeling, intense inflammatory response, massive elastic fibers destruction and abundant collagen deposition. Increased pro- and active MMP-2 was demonstrated in the AAA and controls groups, whereas pro- and active MMP-9 were found to be expressed only in the AAA group. Conclusions: MMP-2 and MMP-9 may have a pivotal role in the development of experimental AAA. This model can help to elucidate the mechanisms which trigger off MMP-2 and MMP-9 secretion and activation causing aneurysms.

INTRODUÇÃO: A síndrome de Williams-Beuren (SWB) é uma doença genética causada por uma microdeleção na região 7q11.23 e caracterizada por dismorfismos faciais típicos, deficiência intelectual, comportamento hipersociável, cardiopatia congênita, principalmente a estenose aórtica supravalvar (EASV), e outras malformações variáveis. MÉTODOS: Foram avaliados 65 pacientes (40 do sexo masculino, 25 do sexo feminino), com idades entre 2 e 59 anos (mediana = 14 anos), com características clínicas sugestivas de SWB. Todos os pacientes eram filhos de pais normais. A técnica de Multiplex Ligation-dependent Probe Amplification® (MLPA®) foi usada com kit específico com sondas da região da SWB (MRC Holland). As sondas foram hibridadas ao DNA e os fragmentos ligados foram amplificados por PCR e analisados com software específico. RESULTADOS: A deleção de todas as sondas da região 7q11.23 testadas foi detectada por MLPA® em 55/65 pacientes. Um caso de deleção atípica, ou seja, menor que 1,5 Mb, foi observada em um paciente com quadro clínico parcial da síndrome. Os nove pacientes sem deleção tinham um diagnóstico clínico duvidoso da SWB. Dois pacientes tiveram MLPA® positivo para SWB embora apresentassem resultados de FISH negativos. Os achados clínicos dos pacientes com deleção típica foram: fácies típica (98,2%), atraso do desenvolvimento neuropsicomotor (98,2%), comportamento hipersociável (94,5%), hiperacusia (94,5%) e cardiopatia (81,8%). Dentre os pacientes com cardiopatia, 42,2% apresentavam EASV (isolada ou associada a outras anomalias cardíacas), 26,7% apresentavam estenose pulmonar e 31,1% apresentavam outras cardiopatias isoladas ou em associação. Outros achados dos pacientes com deleção foram: anormalidades geniturinárias (85,4%), escoliose (56,4%), baixa estatura (43,6%), hérnias inguinais e/ou umbilicais (36,4%), hipertensão arterial (36,4%, com 20% destes apresentando estenose de artérias renais), estrabismo (34,5%), microcefalia (30,9%), sinostose radioulnar (10,9%), hipotireoidismo (14,5%) e hipotireoidismo subclínico (7,3%). Hipercalcemia foi detectada em um paciente apenas. Outros dois pacientes apresentaram nefrocalcinose e um paciente apresentou hipercalciúria, com níveis de cálcio sérico normais. Três pacientes adolescentes foram a óbito por causas cardiovasculares, incluindo um caso de óbito após transplante cardíaco. CONCLUSÕES: A técnica de MLPA® foi eficaz na detecção da microdeleção na região 7q11.23 possibilitando a confirmação diagnóstica da SWB em 84,6% dos pacientes estudados. Além disso, foi possível detectar uma deleção menor atípica em um paciente com fenótipo parcial e confirmar o diagnóstico em dois pacientes com quadro clínico típico de SWB e resultados de FISH negativos. Portanto, o MLPA® constitui-se um método promissor na investigação diagnóstica da SWB. Por ser uma doença multissistêmica, a SWB exige cuidados multidisciplinares e acompanhamento específico a fim de se prevenir complicações / INTRODUCTION: Williams-Beuren syndrome (WBS) is a genetic disorder caused by a microdeletion in 7q11.23 region. It is characterized by typical facial dysmorphisms, mental retardation, hipersociable behavior, congenital heart disease, mainly supravalvular aortic stenosis (SVAS), and other variable congenital malformations. METHODS: 65 patients (40 males, 25 females), aged 2-59 years old (median = 14 years old), with clinical characteristics suggesting WBS, were evaluated. All patients had normal parents. Multiplex Ligation-dependent Probe Amplification® (MLPA®) was performed with a kit with probes in WBS region (MRC Holland). The probes were hybridized to the DNA and the ligated fragments were amplified by PCR and analyzed with specific software. RESULTS: The deletion for all tested probes in the 7q11.23 region was detected by MLPA® in 55/65 patients. One case of atypical deletion, smaller than 1.5 Mb, was observed in one patient with partial clinical picture of the syndrome. The nine patients without the deletion did not have a definitive clinical diagnosis of WBS. Two patients had positive MLPA® results even though they had negative FISH for WBS. The clinical characteristics of the patients with the typical deletion were: typical facies (98.2%), neuropsicomotor delay (98.2%), hypersociable behavior (94.5%), hyperacusis (94.5%) and congenital heart disease (81.8%). Among the patients with cardiac abnormalities, 42.2% had SVAS (isolated or not), 26.7% had pulmonary valve stenosis and 31.1% had other cardiac anomalies (isolated or grouped). Other findings in patients with deletion comprised: genitourinary abnormalities (85.4%), scoliosis (56.4%), short stature (43.6%), inguinal and/or umbilical hernias (36.4%), arterial hypertension (36.4%, with 20% of these presenting renal arteries stenosis), strabismus (34.5%), microcephaly (30.9%), radioulnar synostosis (10.9%), hypothyroidism (14.5%), and subclinical hypothyroidism (7.3%). Hypercalcaemia was detected in only one patient. Two other patients had nephrocalcinosis and one patient had hypercalciuria, with normal serum calcium levels. Three adolescents died due to cardiovascular problems, including one case that died after a cardiac transplantation. CONCLUSIONS: MLPA® was effective to detect the microdeletion in 7q11.23 region confirming the diagnosis of WBS in 84.6% of the patients. It was also possible to detect a small atypical deletion in one patient with partial phenotype and confirm the diagnosis in two patients with typical clinical characteristics of WBS and negative FISH results. Thus, MLPA® is a promising method in the diagnostic investigation of WBS. WBS is a multisystemic disorder and therefore requires multidisciplinary care and specific follow-up in order to prevent complications